Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

被引:58
作者
Kesselheim, Aaron S. [1 ,3 ]
Gagne, Joshua J. [1 ,3 ]
Franklin, Jessica M. [1 ,3 ]
Eddings, Wesley [1 ,3 ]
Fulchino, Lisa A. [1 ,3 ]
Avorn, Jerry [1 ,3 ]
Campbell, Eric G. [2 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St Suite 3030, Boston, MA USA
[2] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
generic drugs; patient survey; FDA; BRAND-NAME; QUESTIONNAIRE; SUBSTITUTION; ATTITUDES; OUTCOMES; BELIEFS;
D O I
10.1007/s11606-016-3612-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Over 84 % of all prescriptions in the US are filled as generic drugs, though in prior surveys, patients reported concerns about their quality. We aimed to survey patients' perceptions and use of generic drugs. Our survey (administered August 2014) assessed patients' skepticism about generic drug safety and effectiveness and how often they requested brand-name drugs. Chi-square tests and two-sample t-tests assessed associations between patient demographics and the outcomes. Our sample frame was the CVS Advisor Panel, a national database of 124,621 CVS customers. We randomly selected 1450 patients with self-reported chronic conditions who filled at least one prescription in the prior 3 months. We assessed how often patients reported asking their physicians to prescribe a brand-name over a generic drug in the last year, and "generic skepticism," defined as not believing generic drugs were as safe, effective, had the same side effects, and contained the same active ingredients as brand-name drugs. Of the 1,442 patients with valid addresses, 933 responded (65 % response rate) and 753 took the full survey. A vast majority (83 %) agreed that physicians should prescribe generic drugs when available, and 54 % said they had not asked their physicians to prescribe a brand-name drug over a generic in the past year. Most respondents considered generic drugs to be as effective (87 %) and safe (88 %) as their brand-name counterparts, and to have the same side effects (80 %) and active ingredients (84 %). Non-Caucasians were more likely than Caucasians to request a brand-name drug over a generic (56 % vs. 43 %, p < 0.01), and were also more skeptical of generic drugs' clinical equivalence (43 % vs. 29 %, p < 0.01). We found a substantial shift towards more patients having positive views of generic drugs, but lingering negative perceptions will have to be overcome to ensure continued cost-savings and improved patient outcomes from generic drugs.
引用
收藏
页码:609 / 614
页数:6
相关论文
共 32 条
[1]   Race and trust in the health care system [J].
Boulware, LE ;
Cooper, LA ;
Ratner, LE ;
LaVeist, TA ;
Powe, NR .
PUBLIC HEALTH REPORTS, 2003, 118 (04) :358-365
[2]   Interval estimation for a binomial proportion - Comment - Rejoinder [J].
Brown, LD ;
Cai, TT ;
DasGupta, A ;
Agresti, A ;
Coull, BA ;
Casella, G ;
Corcoran, C ;
Mehta, C ;
Ghosh, M ;
Santner, TJ ;
Brown, LD ;
Cai, TT ;
DasGupta, A .
STATISTICAL SCIENCE, 2001, 16 (02) :101-133
[3]  
Congressional Budget Office, 2014, COMP COST MED PRESCR
[4]   Brand Name versus Generic Warfarin: A Systematic Review of the Literature [J].
Dentali, Francesco ;
Donadini, Marco P. ;
Clark, Nathan ;
Crowther, Mark A. ;
Garcia, David ;
Hylek, Elaine ;
Witt, Dan M. ;
Ageno, Walter .
PHARMACOTHERAPY, 2011, 31 (04) :386-393
[5]  
Department of Justice, 2013, GEN DRUG MAN RANB PL
[6]   Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism [J].
Dong, BJ ;
Hauck, WW ;
Gambertoglio, JG ;
Gee, L ;
White, JR ;
Bubp, JL ;
Greenspan, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (15) :1205-1213
[7]   Assessing lay beliefs about generic medicines: Development of the generic medicines scale [J].
Figueiras, Maria J. ;
Alves, Nuno C. ;
Marcelino, Dalia ;
Cortes, Maria A. ;
Weinman, John ;
Horne, Rob .
PSYCHOLOGY HEALTH & MEDICINE, 2009, 14 (03) :311-321
[8]   Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study [J].
Gagne, Joshua J. ;
Choudhry, Niteesh K. ;
Kesselheim, Aaron S. ;
Polinski, Jennifer M. ;
Hutchins, David ;
Matlin, Olga S. ;
Brennan, Troyen A. ;
Avorn, Jerry ;
Shrank, William H. .
ANNALS OF INTERNAL MEDICINE, 2014, 161 (06) :400-U56
[9]  
Gaither C., 2001, J AM PHARM ASS, V41, P729
[10]  
Government Accountability Office, DRUG PRIC RES SAV GE